APO Research

APO RESEARCH · REPORT

Antacids Tablet

Selected research

Industry Growth & Trends

Global Antacids Tablet Industry Growth and Trends Forecast to 2032

Market perspective

The global Antacids Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antacids Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antacids Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antacids Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antacids Tablet include Bausch Health, CONBA, CR SANJIU, Procter&Gamble, Reckitt Benckiser, Reddy's Laboratories, AstraZeneca, Bayer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antacids Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antacids Tablet market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antacids Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antacids Tablet.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antacids Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antacids Tablet Market by Company

Bausch Health

CONBA

CR SANJIU

Procter&Gamble

Reckitt Benckiser

Reddy's Laboratories

AstraZeneca

Bayer

GlaxoSmithKline

Pfizer

Johnson&Johnson

Sanofi

Takeda Pharmaceutical

Xiuzheng Pharma

Antacids Tablet Segment by Type

Proton Pump Inhibitor

Acid Neutralizers

H2 Antagonist

Antacids Tablet Segment by Application

OTC Drug

Rx Drug

Antacids Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacids Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antacids Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacids Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antacids Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antacids Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Proton Pump Inhibitor Table 2. Major Company of Acid Neutralizers Table 3. Major Company of H2 Antagonist Table 4. Global Antacids Tablet Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antacids Tablet Sales by Type (2021-2026) & (K Units) Table 6. Global Antacids Tablet Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antacids Tablet Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antacids Tablet Sales Market Share in Value by Type (2021-2026) Table 9. Global Antacids Tablet Price by Type (2021-2026) & (US$/Unit) Table 10. Global Antacids Tablet Sales by Type (2027-2032) & (K Units) Table 11. Global Antacids Tablet Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antacids Tablet Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antacids Tablet Sales Market Share in Value by Type (2027-2032) Table 14. Global Antacids Tablet Price by Type (2027-2032) & (US$/Unit) Table 15. North America Antacids Tablet Sales by Type (2021-2026) & (K Units) Table 16. North America Antacids Tablet Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antacids Tablet Sales by Type (2021-2026) & (K Units) Table 18. Europe Antacids Tablet Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antacids Tablet Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Antacids Tablet Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antacids Tablet Sales by Type (2021-2026) & (K Units) Table 22. Latin America Antacids Tablet Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antacids Tablet Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Antacids Tablet Sales by Type (2021-2026) & (US$ Million) Table 25. Antacids Tablet Industry Trends Table 26. Antacids Tablet Industry Drivers Table 27. Antacids Tablet Industry Opportunities and Challenges Table 28. Antacids Tablet Industry Restraints Table 29. Global Antacids Tablet Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antacids Tablet Revenue Market Share by Company (2021-2026) Table 31. Global Antacids Tablet Sales by Company (2021-2026) & (K Units) Table 32. Global Antacids Tablet Sales Share by Company (2021-2026) Table 33. Global Antacids Tablet Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Antacids Tablet Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antacids Tablet Major Company Production Sites and Headquarters Table 36. Global Antacids Tablet Company, Product Type & Application Table 37. Global Antacids Tablet Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antacids Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antacids Tablet Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antacids Tablet Sales by Region (2021-2026) & (K Units) Table 42. Global Antacids Tablet Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antacids Tablet Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antacids Tablet Sales Market Share in Value by Region (2021-2026) Table 45. Global Antacids Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Antacids Tablet Sales by Region (2027-2032) & (K Units) Table 47. Global Antacids Tablet Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antacids Tablet Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antacids Tablet Sales Market Share in Value by Region (2027-2032) Table 50. Global Antacids Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Antacids Tablet Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antacids Tablet Sales by Application (2021-2026) & (K Units) Table 53. Global Antacids Tablet Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antacids Tablet Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antacids Tablet Sales Market Share in Value by Application (2021-2026) Table 56. Global Antacids Tablet Price by Application (2021-2026) & (US$/Unit) Table 57. Global Antacids Tablet Sales by Application (2027-2032) & (K Units) Table 58. Global Antacids Tablet Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antacids Tablet Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antacids Tablet Sales Market Share in Value by Application (2027-2032) Table 61. Global Antacids Tablet Price by Application (2027-2032) & (US$/Unit) Table 62. North America Antacids Tablet Sales by Application (2021-2026) & (K Units) Table 63. North America Antacids Tablet Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antacids Tablet Sales by Application (2021-2026) & (K Units) Table 65. Europe Antacids Tablet Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antacids Tablet Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Antacids Tablet Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antacids Tablet Sales by Application (2021-2026) & (K Units) Table 69. Latin America Antacids Tablet Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antacids Tablet Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Antacids Tablet Sales by Application (2021-2026) & (US$ Million) Table 72. Bausch Health Company Information Table 73. Bausch Health Business Overview Table 74. Bausch Health Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bausch Health Antacids Tablet Product Portfolio Table 76. Bausch Health Recent Development Table 77. CONBA Company Information Table 78. CONBA Business Overview Table 79. CONBA Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. CONBA Antacids Tablet Product Portfolio Table 81. CONBA Recent Development Table 82. CR SANJIU Company Information Table 83. CR SANJIU Business Overview Table 84. CR SANJIU Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. CR SANJIU Antacids Tablet Product Portfolio Table 86. CR SANJIU Recent Development Table 87. Procter&Gamble Company Information Table 88. Procter&Gamble Business Overview Table 89. Procter&Gamble Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Procter&Gamble Antacids Tablet Product Portfolio Table 91. Procter&Gamble Recent Development Table 92. Reckitt Benckiser Company Information Table 93. Reckitt Benckiser Business Overview Table 94. Reckitt Benckiser Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Reckitt Benckiser Antacids Tablet Product Portfolio Table 96. Reckitt Benckiser Recent Development Table 97. Reddy's Laboratories Company Information Table 98. Reddy's Laboratories Business Overview Table 99. Reddy's Laboratories Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Reddy's Laboratories Antacids Tablet Product Portfolio Table 101. Reddy's Laboratories Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Antacids Tablet Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Bayer Company Information Table 108. Bayer Business Overview Table 109. Bayer Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bayer Antacids Tablet Product Portfolio Table 111. Bayer Recent Development Table 112. GlaxoSmithKline Company Information Table 113. GlaxoSmithKline Business Overview Table 114. GlaxoSmithKline Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GlaxoSmithKline Antacids Tablet Product Portfolio Table 116. GlaxoSmithKline Recent Development Table 117. Pfizer Company Information Table 118. Pfizer Business Overview Table 119. Pfizer Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Pfizer Antacids Tablet Product Portfolio Table 121. Pfizer Recent Development Table 122. Johnson&Johnson Company Information Table 123. Johnson&Johnson Business Overview Table 124. Johnson&Johnson Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Johnson&Johnson Antacids Tablet Product Portfolio Table 126. Johnson&Johnson Recent Development Table 127. Sanofi Company Information Table 128. Sanofi Business Overview Table 129. Sanofi Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Sanofi Antacids Tablet Product Portfolio Table 131. Sanofi Recent Development Table 132. Takeda Pharmaceutical Company Information Table 133. Takeda Pharmaceutical Business Overview Table 134. Takeda Pharmaceutical Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Takeda Pharmaceutical Antacids Tablet Product Portfolio Table 136. Takeda Pharmaceutical Recent Development Table 137. Xiuzheng Pharma Company Information Table 138. Xiuzheng Pharma Business Overview Table 139. Xiuzheng Pharma Antacids Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Xiuzheng Pharma Antacids Tablet Product Portfolio Table 141. Xiuzheng Pharma Recent Development Table 142. North America Antacids Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Antacids Tablet Sales by Country (2021-2026) & (K Units) Table 144. North America Antacids Tablet Sales Market Share by Country (2021-2026) Table 145. North America Antacids Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Antacids Tablet Sales Market Share Forecast by Country (2027-2032) Table 147. North America Antacids Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Antacids Tablet Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Antacids Tablet Market Share by Country (2021-2026) Table 150. North America Antacids Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Antacids Tablet Market Share Forecast by Country (2027-2032) Table 152. Europe Antacids Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Antacids Tablet Sales by Country (2021-2026) & (K Units) Table 154. Europe Antacids Tablet Sales Market Share by Country (2021-2026) Table 155. Europe Antacids Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Antacids Tablet Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Antacids Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Antacids Tablet Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Antacids Tablet Market Share by Country (2021-2026) Table 160. Europe Antacids Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Antacids Tablet Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Antacids Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Antacids Tablet Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Antacids Tablet Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Antacids Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Antacids Tablet Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Antacids Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Antacids Tablet Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Antacids Tablet Market Share by Country (2021-2026) Table 170. Asia-Pacific Antacids Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Antacids Tablet Market Share Forecast by Country (2027-2032) Table 172. Latin America Antacids Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Antacids Tablet Sales by Country (2021-2026) & (K Units) Table 174. Latin America Antacids Tablet Sales Market Share by Country (2021-2026) Table 175. Latin America Antacids Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Antacids Tablet Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Antacids Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Antacids Tablet Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Antacids Tablet Market Share by Country (2021-2026) Table 180. Latin America Antacids Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Antacids Tablet Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Antacids Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Antacids Tablet Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Antacids Tablet Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Antacids Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Antacids Tablet Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Antacids Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Antacids Tablet Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Antacids Tablet Market Share by Country (2021-2026) Table 190. Middle East and Africa Antacids Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Antacids Tablet Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Antacids Tablet Distributors List Table 195. Antacids Tablet Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Antacids Tablet Image Figure 2. Global Antacids Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antacids Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Antacids Tablet Sales (2021-2032) & (K Units) Figure 5. Proton Pump Inhibitor Image Figure 6. Global Proton Pump Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 7. Acid Neutralizers Image Figure 8. Global Acid Neutralizers Sales YoY Growth (2021-2032) & (K Units) Figure 9. H2 Antagonist Image Figure 10. Global H2 Antagonist Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Antacids Tablet Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antacids Tablet Market Share by Type 2025 VS 2032 Figure 13. North America Antacids Tablet Sales Market Share in Volume by Type in 2025 Figure 14. North America Antacids Tablet Sales Market Share in Value by Type in 2025 Figure 15. Europe Antacids Tablet Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antacids Tablet Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antacids Tablet Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antacids Tablet Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antacids Tablet Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antacids Tablet Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antacids Tablet Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antacids Tablet Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antacids Tablet Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. OTC Drug Image Figure 26. Global OTC Drug Sales YoY Growth (2021-2032) & (K Units) Figure 27. Rx Drug Image Figure 28. Global Rx Drug Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Antacids Tablet Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Antacids Tablet Market Share by Application 2025 VS 2032 Figure 31. North America Antacids Tablet Sales Market Share in Volume by Application in 2025 Figure 32. North America Antacids Tablet Sales Market Share in Value by Application in 2025 Figure 33. Europe Antacids Tablet Sales Market Share in Volume by Application in 2025 Figure 34. Europe Antacids Tablet Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Antacids Tablet Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Antacids Tablet Sales Market Share in Value by Application in 2025 Figure 37. Latin America Antacids Tablet Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Antacids Tablet Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Antacids Tablet Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Antacids Tablet Sales Market Share in Value by Application in 2025 Figure 41. North America Antacids Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Antacids Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Antacids Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antacids Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Antacids Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Antacids Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antacids Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Antacids Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Antacids Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antacids Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Antacids Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Antacids Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antacids Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Antacids Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Antacids Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Antacids Tablet Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Antacids Tablet Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Proton Pump Inhibitor
  • Acid Neutralizers
  • H2 Antagonist
Applications
  • OTC Drug
  • Rx Drug
Companies covered
  • Bausch Health
  • CONBA
  • CR SANJIU
  • Procter&Gamble
  • Reckitt Benckiser
  • Reddy's Laboratories
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Johnson&Johnson
  • Sanofi
  • Takeda Pharmaceutical
  • Xiuzheng Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antacids Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antacids Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antacids Tablet Market by Type
  6. 1.3.1 Proton Pump Inhibitor
  7. 1.3.2 Acid Neutralizers
  8. 1.3.3 H2 Antagonist
  9. 1.4 Global Antacids Tablet Market Size by Type
  10. 1.4.1 Global Antacids Tablet Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antacids Tablet Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antacids Tablet Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antacids Tablet Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antacids Tablet Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antacids Tablet Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antacids Tablet Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antacids Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antacids Tablet Industry Trends
  2. 2.2 Antacids Tablet Industry Drivers
  3. 2.3 Antacids Tablet Industry Opportunities and Challenges
  4. 2.4 Antacids Tablet Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antacids Tablet Revenue (2021-2026)
  2. 3.2 Global Top Players by Antacids Tablet Sales (2021-2026)
  3. 3.3 Global Top Players by Antacids Tablet Price (2021-2026)
  4. 3.4 Global Antacids Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antacids Tablet Major Company Production Sites & Headquarters
  6. 3.6 Global Antacids Tablet Company, Product Type & Application
  7. 3.7 Global Antacids Tablet Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antacids Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antacids Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antacids Tablet Tier 1, Tier 2, and Tier 3
4 Antacids Tablet Regional Status and Outlook
  1. 4.1 Global Antacids Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antacids Tablet Historic Market Size by Region
  3. 4.2.1 Global Antacids Tablet Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antacids Tablet Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antacids Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antacids Tablet Forecasted Market Size by Region
  7. 4.3.1 Global Antacids Tablet Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antacids Tablet Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antacids Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antacids Tablet by Application
  1. 5.1 Antacids Tablet Market by Application
  2. 5.1.1 OTC Drug
  3. 5.1.2 Rx Drug
  4. 5.2 Global Antacids Tablet Market Size by Application
  5. 5.2.1 Global Antacids Tablet Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antacids Tablet Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antacids Tablet Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antacids Tablet Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antacids Tablet Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antacids Tablet Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antacids Tablet Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antacids Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bausch Health
  2. 6.1.1 Bausch Health Company Information
  3. 6.1.2 Bausch Health Business Overview
  4. 6.1.3 Bausch Health Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bausch Health Antacids Tablet Product Portfolio
  6. 6.1.5 Bausch Health Recent Developments
  7. 6.2 CONBA
  8. 6.2.1 CONBA Company Information
  9. 6.2.2 CONBA Business Overview
  10. 6.2.3 CONBA Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CONBA Antacids Tablet Product Portfolio
  12. 6.2.5 CONBA Recent Developments
  13. 6.3 CR SANJIU
  14. 6.3.1 CR SANJIU Company Information
  15. 6.3.2 CR SANJIU Business Overview
  16. 6.3.3 CR SANJIU Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CR SANJIU Antacids Tablet Product Portfolio
  18. 6.3.5 CR SANJIU Recent Developments
  19. 6.4 Procter&Gamble
  20. 6.4.1 Procter&Gamble Company Information
  21. 6.4.2 Procter&Gamble Business Overview
  22. 6.4.3 Procter&Gamble Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Procter&Gamble Antacids Tablet Product Portfolio
  24. 6.4.5 Procter&Gamble Recent Developments
  25. 6.5 Reckitt Benckiser
  26. 6.5.1 Reckitt Benckiser Company Information
  27. 6.5.2 Reckitt Benckiser Business Overview
  28. 6.5.3 Reckitt Benckiser Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Reckitt Benckiser Antacids Tablet Product Portfolio
  30. 6.5.5 Reckitt Benckiser Recent Developments
  31. 6.6 Reddy's Laboratories
  32. 6.6.1 Reddy's Laboratories Company Information
  33. 6.6.2 Reddy's Laboratories Business Overview
  34. 6.6.3 Reddy's Laboratories Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Reddy's Laboratories Antacids Tablet Product Portfolio
  36. 6.6.5 Reddy's Laboratories Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Antacids Tablet Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Antacids Tablet Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GlaxoSmithKline Antacids Tablet Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Antacids Tablet Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Johnson&Johnson
  62. 6.11.1 Johnson&Johnson Company Information
  63. 6.11.2 Johnson&Johnson Business Overview
  64. 6.11.3 Johnson&Johnson Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Johnson&Johnson Antacids Tablet Product Portfolio
  66. 6.11.5 Johnson&Johnson Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Antacids Tablet Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
  73. 6.13 Takeda Pharmaceutical
  74. 6.13.1 Takeda Pharmaceutical Company Information
  75. 6.13.2 Takeda Pharmaceutical Business Overview
  76. 6.13.3 Takeda Pharmaceutical Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Pharmaceutical Antacids Tablet Product Portfolio
  78. 6.13.5 Takeda Pharmaceutical Recent Developments
  79. 6.14 Xiuzheng Pharma
  80. 6.14.1 Xiuzheng Pharma Company Information
  81. 6.14.2 Xiuzheng Pharma Business Overview
  82. 6.14.3 Xiuzheng Pharma Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Xiuzheng Pharma Antacids Tablet Product Portfolio
  84. 6.14.5 Xiuzheng Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Antacids Tablet Sales by Country
  2. 7.1.1 North America Antacids Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antacids Tablet Sales by Country (2021-2026)
  4. 7.1.3 North America Antacids Tablet Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antacids Tablet Market Size by Country
  6. 7.2.1 North America Antacids Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antacids Tablet Market Size by Country (2021-2026)
  8. 7.2.3 North America Antacids Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antacids Tablet Sales by Country
  2. 8.1.1 Europe Antacids Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antacids Tablet Sales by Country (2021-2026)
  4. 8.1.3 Europe Antacids Tablet Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antacids Tablet Market Size by Country
  6. 8.2.1 Europe Antacids Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antacids Tablet Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antacids Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antacids Tablet Sales by Country
  2. 9.1.1 Asia-Pacific Antacids Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antacids Tablet Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antacids Tablet Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antacids Tablet Market Size by Country
  6. 9.2.1 Asia-Pacific Antacids Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antacids Tablet Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antacids Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antacids Tablet Sales by Country
  2. 10.1.1 South America Antacids Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antacids Tablet Sales by Country (2021-2026)
  4. 10.1.3 South America Antacids Tablet Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antacids Tablet Market Size by Country
  6. 10.2.1 South America Antacids Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antacids Tablet Market Size by Country (2021-2026)
  8. 10.2.3 South America Antacids Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antacids Tablet Sales by Country
  2. 11.1.1 Middle East and Africa Antacids Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antacids Tablet Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antacids Tablet Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antacids Tablet Market Size by Country
  6. 11.2.1 Middle East and Africa Antacids Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antacids Tablet Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antacids Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antacids Tablet Value Chain Analysis
  2. 12.1.1 Antacids Tablet Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antacids Tablet Production Mode & Process
  7. 12.2 Antacids Tablet Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antacids Tablet Distributors
  10. 12.2.3 Antacids Tablet Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research